Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prodrug compounds activated by AKR1C3 and their use for treating hyperproliferative disorders

Prodrug compounds activated by AKR1C3 and their use for treating hyperproliferative disorders

US Patent 11661404 · Granted May 30, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FGFR kinase inhibitors and pharmaceutical uses2021
FGFR kinase inhibitors and pharmaceutical uses2021
FGFR kinase inhibitors and pharmaceutical uses2021
FGFR kinase inhibitors and pharmaceutical uses2021
Kinase inhibitor prodrug for the treatment of cancer2019
Kinase inhibitor prodrug for the treatment of cancer2019
Kinase inhibitor prodrug for the treatment of cancer2019
Bacterial nitroreductase enzymes and methods relating thereto2019
Bacterial nitroreductase enzymes and methods relating thereto2019
Bacterial nitroreductase enzymes and methods relating thereto2019
Bacterial nitroreductase enzymes and methods relating thereto2019
Prodrugs and methods of use thereof2019